مجموعة أدوات تسجيل مبيدات الآفات

Studies

#120 Accession no. of sample in a recognized culture collection
[addselectioncriteria] [content to be added]
121 Test procedures and criteria to characterize the strain or serotype
[addselectioncriteria] [content to be added]
122 For mutant or genetically-modified strains, indicate all known differences between the modified micro-organism and the parent wild strain(s)
[addselectioncriteria] [content to be added]
123 Trade names, common names, developmental code name
[addselectioncriteria] [content to be added]
124 Indigenous or non-indigenous at the species level to the intended area of application.
[addselectioncriteria] [content to be added]
125 Concentration of microorganism (and relevant secondary compound (metabolite), if appropriate) in terms of g/kg or g/L (also in % w/w) and CFU or biopotency units
[addselectioncriteria] [content to be added]
126 Composition of microbial material used for manufacture of end use products in terms of g/kg or g/L for each active ingredient including microbial and non-microbial impurities.
[addselectioncriteria] [content to be added]
127 Methods of production and quality criteria for the production and storage of the active microorganism; including quality control measures and information on human/mammalian pathogens.
[addselectioncriteria] [content to be added]
128 Quality control data (measures of quality criteria) from 3 - 5 production batches, including storage stability data.
[addselectioncriteria] [content to be added]
129 The formation, presence and/or impact of unintentional ingredients (theoretical discussion)
[addselectioncriteria] [content to be added]
1 2 3 4 5 ... 23